Telemedicine is one of the fastest growing segments in healthcare. The global telemedicine market was estimated to be worth around $17.9 billion in 2015, and it is forecast to grow at 18.7% annually from 2016 to 2022, according to P&S Market Research. that the number of patients using telemedicine services will reach 7 million by 2018, up from less than 350,000 in 2013. At Auriga, we believe that the telemedicine industry will see tremendous development in the coming years, and we are striving to deliver sophisticated and high-quality solutions to our customers. Continue reading
Just as people need to speak a common language to understand each other, computer applications need to communicate with a common protocol to share data. HL7 protocol development started in 1987 to allow healthcare applications to securely exchange clinical data with each other. Over time, HL7 has become globally accepted, widely accredited, and recognized as the most commonly used set of interoperability standards in the world. Continue reading
After a series of developments, mobile devices are now being leveraged in the medical sector as a reliable tool in tracking the health of patients and assisting professionals in managing their daily workload. In fact, wearables and mobile health app usage has increased by 50% from 2014 to 2016. Experts state this can be accounted to the wide adoption of mobile technologies by both consumers and the industry itself.
But what does the future hold for the medical mobile health assistance? Should we expect new innovations or just new apps? Continue reading
In April, Auriga’s experts plan to attend two great events, BIOMEDevice and the Embedded Systems Conference (ESC), to share our experience and network with the leading experts, current customers, and prospective leads. Both events will take place on April 13–14 at the Boston Convention & Exhibition Center in Boston, MA. Continue reading